VTAK (Catheter Precision Corp) Earnings growth forecast for next year

Catheter Precision brings together elite biomedical engineers and electrophysiology experts to implement innovative ablation navigation systems. This chart of the consensus EPS n+1 forecast on the GURU.Markets platform shows that 0.00 is the current level of the indicator. High business margins are driven by the mass production of patented catheters, ensuring efficient scalability alongside stable personnel costs.

Catheter Precision Corporation (VTAK): Expected earnings per share trend next year from 02/21/2024 to 10/05/2026

catheterprecision.com (VTAK) - metric breakdowns and financial figures

- stock quotes and analyst forecast:

Stock Quotes Catheter Precision Corp|VTAK - Analyst Forecast Prices

- business market valuation indicators:

Market Capitalization Catheter Precision|VTAK - Total Enterprise Value

- book capitalization indicators:

Net Assets per Single Share Catheter Precision|VTAK - Accounting Value of Company|Market Cap to Net Assets Ratio catheterprecision.com|VTAK - Aggregate Asset Value

- issuer credit burden and liquidity indicators:

- net income and valuation ratios data:

VTAK - Net Financial Result|Expected Profit Catheter Precision|VTAK - Business Payback Period|Forward P/E Multiple Catheter Precision|VTAK - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Catheter Precision|VTAK - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Catheter Precision|VTAK - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months catheterprecision.com|VTAK - Earnings per share growth in current year|Expected earnings per share growth for next year Catheter Precision

Fundamental company valuation:Catheter Precision Corp, VTAK

Core merchandise of Catheter Precision, Inc.

The selection of high-quality issuers is based on the business's ability to generate excess cash flow, which is validated through an analysis of expected earnings growth for the coming period. This metric assesses yield sustainability and leverage risk, while the history of consensus earnings estimates for the following year reflects the success of Catheter Precision (VTAK) in expanding within the electrophysiology market and implementing high-precision arrhythmia treatment systems.

Competitors of Catheter Precision